Skip to main content

Sergio Cabello

Institutions of which they are part

Research technician
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Sergio Cabello

Institutions of which they are part

Research technician
Clinical Neuroimmunology
Vall Hebron Institut de Recerca

Projects

Caracterización estructural y funcional de la vía visual anterior en pacientes con esclerosis múltiple temprana (VISIONEM).

IP: Angela Vidal Jordana
Collaborators: Dulce María Moncho Rodríguez, Alex Rovira Cañellas, Manel Alberich Jordà, Neus Mongay Ochoa, Joaquin Castillo Justribo, Sergio Cabello
Funding agency: Instituto de Salud Carlos III
Funding: 48400
Reference: PI22/01589
Duration: 01/01/2023 - 31/12/2025

SGR-Cat 2021: Neuroimmunologia Clínica

IP: SGR-Cat 2021: Neuroimmunologia Clínica
Collaborators: Carlos Nos Llopis, SGR-Cat 2021: Neuroimmunologia Clínica, José Ant. Graells Salvador, Jaume Sastre Garriga, Jordi Rio Izquierdo, Ingrid Galán Cartaña, Rosalia Horno Ocaña, Manuel Comabella Lopez, Andrea Serrano Mascarós, Margarida Capell Maymo, Samuel Sánchez Pous, Elisenda Anglada Clofent, Montserrat Aroca Alsina, Sergio Cabello, Carmen Tur Gomez, Gabriel Ig Camiña Rodríguez, Herena Eixarch Ahufinger, Carme Santoyo Medina, Oriol Nualart Mundo, Mar Tintore Subirana, M Jesus Arevalo Navines, Edwin Roger Meza Murillo, Augusto Cesar Sao Aviles, Miguel Angel Robles Sanchez, Dunia Muñoz Valdivielso, Carmen Espejo Ruiz, Gaizka Loyola Sanmillan, Mireia Resina Salles, Angela Vidal Jordana, Lucía Gutiérrez Ruiz, Ana Zabalza de Torres, Sergio Vergara Ruiz, Rafael Garcia Merida, Luciana Midaglia Fernandez, Alvaro Cobo Calvo, Neus Mongay Ochoa, Joaquin Castillo Justribo, Milagros Fraga Pereira, Breogan Rodriguez Acevedo, Andres Miguez Gonzalez, Mireia Castillo Juarez, Rucsanda Pinteac, Nicolás Miguel Fissolo
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 40000
Reference: 2021 SGR 00782
Duration: 01/01/2022 - 30/06/2025

TRAtamiento y recuperación VISual en neuritis óptica - Estudio TRAVIS

IP: Jaume Sastre Garriga
Collaborators: Dulce María Moncho Rodríguez, Sergio Cabello, Cristina Auger Acosta, Alex Rovira Cañellas, Ana Zabalza de Torres, Joaquin Castillo Justribo
Funding agency: Instituto de Salud Carlos III
Funding: 96800
Reference: PI19/00950
Duration: 01/01/2020 - 30/06/2024

Related news

Anti-Müllerian hormone had been proposed as a potential biomarker for predicting disease prognosis in women, but this study shows that the observed association is explained by patients’ chronological age.

The Spider-MS tool estimates the probability that a patient will experience various long-term clinical events and will help personalize the follow-up and treatment of each person living with the disease.

The results show that live attenuated vaccines against measles, rubella, mumps and varicella do not increase the risk of relapses in people with multiple sclerosis.

Related professionals

Susana Nuria Ayala Cortes

Susana Nuria Ayala Cortes

Research assistant
Infectious Diseases
Read more
Cristina Vert Roca

Cristina Vert Roca

Postdoctoral researcher
Research on Aging, Frailty and Transitions in Barcelona
Read more
Paula Esteban Ibarz

Paula Esteban Ibarz

Predoctoral researcher
Liver Diseases
Read more
Sara Valles Angulo

Sara Valles Angulo

Predoctoral researcher
Neurotraumatology and Neurosurgery Research Unit (UNINN)
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.